Effect of rectal Misoprostol in reducing blood loss before hysterectomy and myomectomy
Phase 2
Recruiting
- Conditions
- terine lymphoma.benign neoplasms of uterus with morphology code M889 and behaviour code /0 fibromyoma of uterus
- Registration Number
- IRCT20181020041394N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age between 35 and 50 years
The number of uterine fibroids is 5 or less
The maximum size of the largest fiber is 3 cm
All fibromas are subserosal or intramural in ultrasound
Uterus size less than 24 weeks pregnant with two-handed examination if need for myomectomy
Exclusion Criteria
Any contraindication for using Misoprostol
The presence of malignancy
History of previous laparotomy except cesarean section
History of endometriosis
Cardiovascular and pulmonary diseases
Bleeding disorders
Hemoglobin below 10 g / dl
Body mass index greater than 30 kg / m²
Previous Myomectomy History
History of using misoprostol with GnRH immediately before surgery
Unwillingness to enter the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method